Mentice AB (publ)
MNTC
Rank in Stocks
#23237
Mentice AB (publ), founded in 1998 and headquartered in Gothenburg, Sweden,... Mentice AB (publ), founded in 1998 and headquartered in Gothenburg, Sweden, specializes in delivering advanced endovascular simulation solutions. These are utilized by educational institutions, healthcare systems, and medical device manufacturers globally, with the company's operations spanning across Europe, the Middle East, Africa, the Asia Pacific region, and the Americas. Its business is structured across distinct segments focusing on the Medical Device Industry, Healthcare Systems, and Strategic Alliances. The company offers a comprehensive suite of software modules designed for training in a wide array of interventional procedures. These include acute ischemic stroke, atrial septal defect/patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee, carotid, and renal interventions, along with patient-specific simulations. The portfolio further encompasses advanced and essential coronary procedures, intermediate coronary, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic and uterine artery embolization, radiation safety, transarterial chemoembolization, transseptal puncture, vascular trauma, and cardiac rhythm management. Additionally, Mentice provides crucial support for interventionalists transitioning from transfemoral to transradial access techniques. Beyond software, Mentice's product line features sophisticated medical simulators for endovascular therapies, accompanied by compatible accessories and extensions. They also supply specialized silicone vasculature, as well as cardiac, vascular, and neurovascular flow systems. Innovative digital offerings include the Mentice Right Heart Cath App, a mobile tool for interactive exploration of right heart catheterization procedures, and the Mentice Live Learning Center, which facilitates remote learning through its VIST G endovascular simulation platform. All these comprehensive solutions are engineered to educate, train, and significantly enhance the skills of medical professionals.
Share Price
$1.57
Last synced: 2026-11-09
Market Cap
$44.19M
Change (1 day)
3.27%
Change (1 year)
10.49%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Mentice AB (publ) (MNTC)
Category
Healthcare
EPS for Mentice AB (publ) (MNTC)
EPS as of June 2026 TTM: $-0.02
According to Mentice AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.12, a decrease compared to its 2024 EPS of $-0.07.
EPS history for Mentice AB (publ) from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | -85.67% |
| 2025 | $-0.12 | 90.81% |
| 2024 | $-0.07 | 499.08% |
| 2023 | $-0.01 | -90.68% |
| 2022 | $-0.12 | -10.28% |
| 2021 | $-0.13 | 99.69% |
| 2020 | $-0.07 | -41.96% |
| 2019 | $-0.11 | -221.10% |
| 2018 | $0.09 | 192.14% |
| 2017 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -15,797.67% |
US
|
|
| $4.09 | -23,879.07% |
IE
|
|
| $9.45 | -55,041.86% |
US
|
|
| $2.37 | -13,879.07% |
US
|
|
| $1.77 | -10,390.70% |
US
|
Questions about Mentice AB (publ)'s earnings per share (EPS)
What is Mentice AB (publ)'s earnings per share (EPS)?
Mentice AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.02, as of Jun 2026.
What was Mentice AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Mentice AB (publ)'s earnings per share (EPS) was $-0.12, compared with $-0.07 in 2024.
How has Mentice AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Mentice AB (publ)'s earnings per share (EPS) was highest in 2023 ($-0.01) and lowest in 2021 ($-0.13).
How does Mentice AB (publ)'s earnings per share (EPS) compare with similar companies?
Mentice AB (publ)'s earnings per share (EPS) ($-0.02) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.